Serotonin syndrome: A clinical update

Critical Care Clinics

Volumn 13, Issue 4, 1997, Pages 763-783

  Mills, K C ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; AUTONOMIC DYSFUNCTION; COMA; CONFUSION; HUMAN; HYPERREFLEXIA; MYOCLONUS; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN SYNDROME;

EID: 0030862983     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70368-7     Document Type: Article

References (113)

1. G.K. Aghajanian Serotonin and the action of LSD in the brain Psychiatric Annals 24 1994 137 141
2. D. Ames W.C. Wirshing Ectasy, the serotonin syndrome, and neuroleptic malignant syndrome-A possible link? JAMA 269 1993 869 870
3. F.J. Ayd Toxic somatic and psychopathologic reactions to antidepressant drugs J Neuropsychiatry 2 suppl 1961 119 122
4. E.C. Azmitia P. Whitaker-Azmitia Awakening the sleeping giant: Anatomy and plasticity of the brain serotonergic system J Clin Psychiatry 52 suppl 12 1991 4 16
5. W. Babiak Case fatality due to overdosage of a combination of tranylcypromine and imipramine Can Med J 85 1961 377
6. M. Baetz D. Malcolm Serotonin syndrome from fluvoxamine and buspirone Can J Psychiatry 40 1995 428 429
7. R.W. Baloh J. Dietz J.W. Spooner Myoclonus and ocular oscillations induced by l -tryptophan Ann Neurol 11 1982 95 97
8. A. Baskys G. Remington Serotonin and dopamine as neurotransmitters Baskys A. Remington G. Brain Mechanisms and Psychotropic Drugs 1996 CRC Press New York 55 63
9. H.G. Baumgarten Z. Grozdanovic Psychopharmacology of central serotonergic systems Pharmacopsychiatry 28 1995 73 79
10. Beasley C.M. Jr D.N. Masica J.H. Heilgenstein Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: Fluoxetine clinical data and preclinical findings J Clin Psychopharmacol 13 1993 312 320
11. R.A. Bodner T. Lynch L. Lewis Serotonin syndrome Neurology 45 1995 219 223
12. J.M. Bostwick T.M. Brown A toxic reaction from combining fluoxetine and phentermine J Clin Psychopharmacol 16 1996 189 190
13. J. Branchfield A. Wirtshafter S. Wolfe Imipramine-tranylcypromine incompatibility JAMA 186 1963 1172 1173
14. S.K. Brannan B.J. Talley C.L. Bowden Sertraline and isocarboxazid cause a serotonin syndrome J Clin Psychopharmacol 14 1994 144 145
15. D. Brennan M.M. Manus J. Howe “Neuroleptic malignant syndrome” without neuroleptics Br J Psychol 152 1988 578 579
16. T.R. Brodribb M. Downey P.J. Gilbar Efficacy and adverse effects of moclobemide Lancet 343 1994 475
17. T.M. Brown Nitroglycerin in the treatment of the serotonin syndrome Ann Pharmacother 30 1996 191
18. T.M. Brown B.P. Skop Pathophysiology and management of the serotonin syndrome Ann Pharmacother 30 1996 527 533
19. B. Browne S. Linter Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment Br J Psychiatry 51 1987 210 212
20. J.R. Brubacher R.S. Hoffman M.J. Lurin Serotonin syndrome from venlafaxine-tranylcypromine interaction Vet Hum Toxicol 38 1996 358 361
21. J.L. Cano-Munoz M.L. Montejo-Iglesias I.M. Borrero-Galvez Possible serotonin syndrome following the combined administration of clomipramine and alprazolam J Clin Psychiatry 56 1995 122
22. J.R. Cooper F.E. Bloom R.H. Roth Serotonin (5-hydroxytryptamine) and histamine The Biochemical Basis of Neuropharmacology ed 7 1996 Oxford University Press New York 352 390
23. J.D. Coplan J.M. Gorman Detectable levels of fluoxetine after discontinuation: An unexpected serotonin syndrome Am J Psych 150 1993 837
24. M.A. Corkeron Serotonin syndrome: A potentially complication of antidepressant therapy Med J Aust 163 1995 481 482
25. S.C. Curry F.A. Agnone K.C. Mills Neurotransmitter principles Goldfrank L.R. Flomenbaun N.E. Lewin N.A. Gold Franks Toxicologic Emergencies ed 5 1994 Appleton and Lange 243 245
26. G. Davis Side-effects of phenelzine BMJ 2 1960 1019
27. M. Demirkiran J. Jankovic J.M. Dean Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome Clin Neuropharmacol 19 1996 157 164
28. P.H. Denton V.M. Borrelli N.V. Edwards Dangers of monoamine oxidase inhibitors BMJ 2 1962 1752 1753
29. P. Fischer Serotonin syndrome in the elderly after antidepressive monotherapy J Clin Psychopharmacol 15 1995 440 442
30. E. Francis F. Harchelroad LSD/fluoxetine-induced serotonin syndrome [abstract] J Toxicol Clin Toxicol 34 1996 560
31. A. Frazer J. Hensler Serotonin Siegel G.J. Agranoff B.W. Albers R.W. Basic Neurochemistry ed 5 1994 Raven Press New York 283 308
32. R.W. Fuller Drugs affecting serotonin neurons Prog Drug Res 35 1990 85 108
33. T.P. George L.S. Godleski Possible serotonin syndrome with trazodone addition to fluoxetine Biol Psychol 39 1996 383 386
34. S.C. Gerson R.J. Baldessarini Motor effects of serotonin in the central nervous system Life Sci 27 1980 1435 1451
35. M.J. Gitlin Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome J Clin Psychopharmacol 17 1997 66 67
36. 2 agonists or antagonists? Neuropsychopharmacol 3 1990 509 517
37. R.A. Glennon N.A. Darmani B.R. Martin Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents Life Sci 48 1991 2493 2498
38. R.J. Goldberg M. Huk Serotonin syndrome from trazodone and buspirone Psychosomatics 33 1992 235 236
39. M.A. Graber T.B. Hoehns P.J. Perry Sertraline-phenelzine drug interaction: A serotonin syndrome reaction Ann Pharmacother 28 1994 732 735
40. P.M. Graham J.M. Potter J. Paterson Combination monoamine oxidase inhibitor/tricyclic antidepressant interaction Lancet 2 1982 440
41. J. Grantham W. Neel R.W. Brown Reversal of imipramine-monoamine oxidase inhibitor induced toxicity with chlorpromazine J Kans Med Soc 65 1964 279 280
42. B.H. Guze L.R. Baxter The serotonin syndrome: Case responsive to propranolol J Clin Psychopharmacol 6 1986 119 120
43. M. Halman D.S. Goldbloom Fluoxetine and neuroleptic malignant syndrome Biol Psychol 28 1990 518 521
44. T.E. Hansen K. Dieter G.A. Keeper Interaction of fluoxetine and pentazocine Am J Psychol 147 1990 949 950
45. D.J. Heal G.P. Luscombe K.F. Martin Pharmacological identification of 5-HT: Receptor subtypes using behavioral models Marsden C.A. Heal D.J. Central Serotonin Receptors and Psychotropic Drugs 1992 Blackwell Scientific Boston 56 99
46. M.A. Heisler J.R. Guidry B. Arnecke Serotonin syndrome induced by administration of venlafaxine and phenelzine Ann Pharmacother 30 1996 84
47. J.A. Henry K.J. Jeffreys S. Dawling Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”) Lancet 340 1992 384 387
48. A.F. Hernandaz M.N. Montero A. Pla Fatal moclobemide overdose or death caused by serotonin syndrome? J Forensic Sci 40 1995 128 130
49. D. Heyland M. Sauve Neuroleptic malignant syndrome without the use of neuroleptics Can Med Assoc J 145 1991 817 819
50. M.J.A.J.M. Hoes J.H.B. Zeijpveld Mirtazapine as treatment for serotonin syndrome Pharmacopsychiatry 29 1996 81
51. T.R. Insel B.F. Roy R.M. Cohen Possible development of the serotonin syndrome in man Am J Psychol 139 1982 954 955
52. B.L. Jacobs An animal behavior model for studying central serotonergic synapses Life Sci 19 1976 777 786
53. B.L. Jacobs H. Klemfuss Brain stem and spinal cord mediation of a serotonergic behavioral syndrome Brain Res 100 1975 450 457
54. J.S. Jahr J.D. Pisto M.C. Gilton The serotonin syndrome in a patient receiving sertraline after an ankle block Anesth Analg 79 1994 189 191
55. C.A. Kaminski M.S. Robbins R.E. Weibley Sertraline intoxication in a child Ann Emerg Med 23 1994 1371 1374
56. N. Keltner Serotonin syndrome: A Case of Fatal SSRI/MAOI interaction Prospective in Psychiatric Care 30 1994 26 31
57. S.S. Kline L.S. Mauro D.M. Scala-Barnett Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death Clin Pharm 8 1989 8510 8514
58. M.J. Kuisma Fatal serotonin syndrome with trismus Ann Emerg Med 26 1995 109
59. R.I. Lappin E.L. Auchincloss Treatment of the serotonin syndrome with cyproheptadine Lancet 343 1994 475
60. M. Lejoyeux J. Ades F. Rouillon Serotonin syndrome Incidence, symptoms and treatment 2 1994 132 143
61. M. Lejoyeux F. Fineyre J. Ades The serotonin syndrome Am J Psychol 149 1992 1410 1411
62. M. Lejoyeux F. Rouillon J. Ades Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine Acta Psychiatr Scand 88 1993 369 371
63. A. Lenzi D. Raffaelli D. Marazziti Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage Pharmacopsychiatry 26 1993 100
64. A.B. Levy P. Bucher N. Votolato Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment Can J Psych 30 1985 434 436
65. J.A. Lieberman J.M. Kane R. Reife Neuromuscular effects of monoamine oxidase inhibitors Adv Neurol 43 1986 231 249
66. A.C. Logan B. Stickle N. O'Keefe Survival following “ecstasy” ingestion with a peak temperature of 42 degree Celsius Anaesthesia 48 1993 1017 1018
67. T.G. Martin Serotonin syndrome Ann Emerg Med 28 5 1996 520 526
68. D. Meyer V. Halfin Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: A case report and critical review J Clin Psychopharmacol 1 1981 319 321
69. F. Miller R. Friedman J. Tanenbaum Disseminated intra-vascular coagulation and acute myoglobinuric renal failure: A consequence of the serotonergic syndrome J Clin Psychopharmacol 11 1991 277 279
70. K.C. Mills Monoamine oxidase inhibitor toxicity Top Emerg Med 5 1993 58 71
71. K.C. Mills Serotonin toxicity: A comprehensive review for emergency medicine Top Emerg Med 15 1993 54 73
72. K.C. Mills Serotonin syndrome Clin Pharmacol 52 1995 1475 1482
73. R.S. Mitchell Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis Ann Intern Med 42 1955 417 424
74. H. Miyaoka K. Kamijima Encephalopathy during amitriptyline therapy: Are neuroleptic malignant syndrome and serotonin malignant syndrome and serotonin syndrome spectrum disorders? Int Clin Psychopharmacol 10 1995 265 267
75. E.C. Muly W. McDonald D. Steffens Serotonin syndrome produced by a combination of fluoxetine and lithium Am J Psychol 150 1993 1565
76. P.J. Neuvonen S. Pohjola-Sintonen U. Tacke Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses Lancet 342 1993 1419
77. D.W. Nierenberg M. Semprebon The central nervous system serotonin syndrome Clin Pharmacol Ther 53 1993 84 88
78. P.K. Nijhawan G. Katz S. Winter Psychiatric illness and the serotonin syndrome: An emerging adverse drug effect leading to intensive care unit admission Crit Care Med 24 1996 1086 1089
79. S.M. Nimmo B.W. Kennedy W.M. Tullett Drug-induced hyperthermia Anaesthsia 48 1993 892 895
80. J.A. Oates A. Sjoerdsma Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor Neurology 10 1960 1076 1078
81. R. Ohman O. Spigset Serotonin syndrome induced by fluvoxamine lithium interaction Pharmacopsychiatry 26 1993 263 264
82. C. Papp S. Benaim Toxic effects of iproniazid in a patient with angina BMJ 2 1958 1070 1072
83. A.E. Peebles-Brown Hyperpyrexia following psychotropic overdose Anaesthesia 40 1985 1097 1099
84. H.G. Pope J.M. Jonas J.I. Hudson Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan Am J Psychol 142 1985 491 492
85. B.M. Power M. Pinder L.P. Hackett Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine Anaesth Inten Care 23 1995 499 502
86. W.A. Price B. Zimmer P. Kucas Serotonin syndrome: A case report J Clin Pharmacol 26 1986 77 78
87. R.R. Reeves J.A. Bullen Serotonin syndrome produced by paroxetine and low-dose trazodone Psychosomatics 36 1995 159 160
88. N. Rivers B. Horner Possible lethal reaction between nardil and dextromethorphan Can Med J 103 1970 85
89. B. Rosenberg C.A. Pearlman NMS-like syndrome with a lithium/doxepin combination J Clin Psychopharmacol 11 1991 75
90. F. Ruiz Fluoxetine and the serotonin syndrome Ann Emerg Med 24 1994 983 985
91. E. Sanders-Bush S.E. Mayer 5-Hydroxytryptamine (serotonin) receptor agonists and antagonist Hardman J.G. Limbird L.E. Molinoff P.B. Goodman and Gillman's The Pharmacological Basis of Therapeutics ed 9 1996 McGraw-Hill New York 249
92. R. Sandyk l -Dopa induced “serotonin syndrome” in a parkinsonian patient on bromocriptine J Clin Psychoparmacol 6 1986 194 195
93. G.R. Screaton H.S. Cairns M. Sarner MDMA toxicity. Hyperpyrexia and rhabdomyolysis after MDMA (“ecstasy”) abuse Lancet 339 1992 677 678
94. Shee CJ: Dangerous potention of pethidine by iproniazid, and its treatment. BMJ 2.
95. H. Singh Atropine-like poisoning due to tranquilizing agents Am J Psychol 117 1960 360 361
96. B.P. Skop J.A. Finkelstein T.R. Mareth The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease Am J Emerg Med 12 1994 642 644
97. M.J. Smilkstein S.C. Smolinski B.H. Rumack A case of MAO inhibitor? MDMA interaction: Agony after the ecstasy J Toxicol Clin Toxicol 25 1987 149 159
98. B. Smith D.J. Prockop Central-nervous-system effects of ingestion of l -tryptophan by normal subjects N Engl J Med 267 1962 1338 1341
99. L.M. Smith S.J. Peroutka Differential effects of 5-hydroxytryptamine selective drugs on the 5-HT behavioral syndrome Pharmacol Biochem Behav 24 1986 1513 1519
100. R. Sovner J. Wolfe Interaction between dextromethorphan and monoamine oxidase inhibitor therapy with isocarboxazid N Engl J Med 319 1988 1671
101. D.S. Spigset T. Mjorndal Serotonin syndrome caused by a moclobemide-clomipramine interaction BMJ 306 1993 248
102. K.M. Spivey C.M. Wait Perioperative seizures and fluvoxamine Br J of Anaesthesia 71 1993 321
103. K.A. Sporer The serotonin syndrome Drug Experience 13 1995 94 104
104. W. Steiner R. Fontaine Toxic reaction following the combined administration of fluoxetine and l -tryptophan: Five cases reports Biol Psychol 21 1986 1067 1071
105. H. Sternbach The serotonin syndrome Am J Psych 148 1991 705 713
106. R.M. Tackley B. Tregaskis Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction Anaesthesia 42 1987 760 763
107. D.C. Taylor Alarming reaction to pethidine in patients on phenelzine Lancet 1962 401 402
108. B. Tehan R. Hardern A. Bodenham Hyperthermia associated with 3,4-methylenedioxyethamphetamine (“Eve”) Anaesthesia 48 1993 507 510
109. J.M. Thomas E.H. Rubin Case report of a toxic reaction from a combination of tryptophan and phenelzine Am J Psychiatry 141 1984 281 283
110. M. VanBerkum J. Theil A. Segovia A fatality due to serotonin syndrome. [abstract] J Toxicol Clin Toxicol 34 1996 559 560
111. I.M. Vigran Dangerous potention of meperidine hydrochloride by pargyline hydrochloride JAMA 187 1964 953 954
112. D.M. Weiss Serotonin syndrome in Parkinson disease Journal of the American Board of Family Practice 8 1995 400 402
113. G.L. Zornberg J.A. Bodkin B.M. Cohen Severe adverse interaction between pethidine and selegiline Lancet 337 1991 246